Related Experiment Videos
[Transfusion and cancer]
1Centre d'Hémobiologie Transfusion, Groupe Hospitalier Pitié-Salpêtrière, Paris.
Summary
Blood transfusions are generally excluded for cancer patients donating blood. Transfusions may increase cancer risk or recurrence, particularly colorectal cancer, and carry risks like tumor cell dissemination and graft-versus-host disease.
Area of Science:
- Oncology
- Transfusion Medicine
- Immunology
Background:
- The relationship between blood transfusion and cancer is complex and multifaceted.
- Cancer patients are typically excluded from blood donation due to potential risks.
- The implications of blood transfusions for cancer patients require careful consideration.
Purpose of the Study:
- To review the relationship between blood transfusion and cancer from multiple perspectives.
- To evaluate the risks and benefits of different transfusion strategies in cancer care.
- To assess the impact of transfusion history on cancer development and recurrence.
Main Methods:
- Literature review and synthesis of existing studies.
- Analysis of five key aspects: cancer patients as donors, autologous transfusion, transfusion history and cancer risk, cancer recurrence, and post-transfusion graft-versus-host disease.
- Discussion of potential mechanisms, including immune alterations and viral transmission.
Main Results:
- Cancer patients are unsuitable blood donors.
- Autologous blood transfusion has limitations, and intraoperative salvage may spread tumor cells.
- Transfusion history may be linked to increased cancer risk and recurrence, especially for colorectal cancer.
- Post-transfusion graft-versus-host disease in cancer patients is rare but possible.
Conclusions:
- Blood transfusion practices require careful consideration in cancer patients.
- Further research, including randomized controlled trials comparing transfusion strategies, is needed.
- Understanding the immunomodulatory effects of transfusions is crucial for cancer management.